These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Antibody response, recurrence patterns and subsequent herpes simplex virus type 2 (HSV-2) re-infection following initial HSV-2 infection of guinea-pigs: effects of acyclovir. Bernstein DI; Stanberry LR; Harrison CJ; Kappes JC; Myers MG J Gen Virol; 1986 Aug; 67 ( Pt 8)():1601-12. PubMed ID: 3016155 [TBL] [Abstract][Full Text] [Related]
8. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus. Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells. Khan AA; Srivastava R; Chentoufi AA; Geertsema R; Thai NT; Dasgupta G; Osorio N; Kalantari M; Nesburn AB; Wechsler SL; BenMohamed L J Virol; 2015 Jul; 89(13):6619-32. PubMed ID: 25878105 [TBL] [Abstract][Full Text] [Related]
10. Early intervention with high-dose acyclovir treatment during primary herpes simplex virus infection reduces latency and subsequent reactivation in the nervous system in vivo. Sawtell NM; Thompson RL; Stanberry LR; Bernstein DI J Infect Dis; 2001 Oct; 184(8):964-71. PubMed ID: 11574910 [TBL] [Abstract][Full Text] [Related]
11. ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latency. Halford WP; Schaffer PA J Virol; 2001 Apr; 75(7):3240-9. PubMed ID: 11238850 [TBL] [Abstract][Full Text] [Related]
12. Treatment of HSV-1 infection with immunoglobulin or acyclovir: comparison of their effects on viral spread, latency, and reactivation. LeBlanc RA; Pesnicak L; Godleski M; Straus SE Virology; 1999 Sep; 262(1):230-6. PubMed ID: 10489356 [TBL] [Abstract][Full Text] [Related]
13. Latent acyclovir-resistant herpes simplex virus type 1 in trigeminal ganglia of immunocompetent individuals. van Velzen M; van Loenen FB; Meesters RJ; de Graaf M; Remeijer L; Luider TM; Osterhaus AD; Verjans GM J Infect Dis; 2012 May; 205(10):1539-43. PubMed ID: 22457282 [TBL] [Abstract][Full Text] [Related]
14. Novel animal model for evaluating topical efficacy of antiviral agents: flux versus efficacy correlations in the acyclovir treatment of cutaneous herpes simplex virus type 1 (HSV-1) infections in hairless mice. Lee PH; Su MH; Kern ER; Higuchi WI Pharm Res; 1992 Aug; 9(8):979-89. PubMed ID: 1329068 [TBL] [Abstract][Full Text] [Related]
15. Long-term observation of herpes simplex virus type 1 (HSV-1) infection in a child with Wiskott-Aldrich syndrome and a possible reactivation mechanism for thymidine kinase-negative HSV-1 in humans. Shiota T; Kurane I; Morikawa S; Saijo M Jpn J Infect Dis; 2011; 64(2):121-6. PubMed ID: 21519125 [TBL] [Abstract][Full Text] [Related]
16. In vitro reactivation of latent herpes simplex virus by the demethylating compound hexamethylene-bis-acetamide. Blondeau JM; Aoki FY J Virol Methods; 1992 Dec; 40(3):323-9. PubMed ID: 1335458 [TBL] [Abstract][Full Text] [Related]
17. An M2 Rather than a T Lee DH; Ghiasi H J Virol; 2018 May; 92(10):. PubMed ID: 29491152 [TBL] [Abstract][Full Text] [Related]
18. [Battle with herpes for 37 years]. Shimomura Y Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):145-66; discussion 167. PubMed ID: 25854108 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo antiherpetic effects of (1R,2R)-1-(5'-methylful-3'-yl)propane-1,2,3-triol. Sasaki K; Hayashi K; Matsuya Y; Sugimoto K; Lee JB; Kurosaki F; Hayashi T J Nat Med; 2016 Apr; 70(2):217-24. PubMed ID: 26763002 [TBL] [Abstract][Full Text] [Related]
20. A temporal analysis of acyclovir inhibition of induced herpes simplex virus type 1 In vivo reactivation in the mouse trigeminal ganglia. Sawtell NM; Bernstein DI; Stanberry LR J Infect Dis; 1999 Sep; 180(3):821-3. PubMed ID: 10438371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]